ADMA Biologics (ADMA) Cash Flow: Operating & Free Cash Flow

ADMA Biologics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for ADMA Biologics, Inc. (ADMA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	146.93	197.67	-28.24	-65.90	-71.65	-75.75	-48.28	-65.74	-43.76
Depreciation & Amortization	8.10	8.05	8.33	7.11	5.50	3.94	3.26	3.45	2.69
Deferred Income Tax	11.02	-84.28	0.00	0.00	0.22	-0.91	0.00	0.12	1.88
Stock Based Compensation	20.03	13.62	6.19	5.22	3.49	2.86	2.65	0.00	1.56
Change in Working Capital	-139.60	-18.54	-10.12	-18.29	-51.68	-33.78	-33.50	-3.69	-0.28
Change in Accounts Receivable	-108.43	-22.58	-11.92	13.07	-15.34	-9.77	-2.08	2.49	-2.86
Change in Inventory	-36.23	2.67	-9.63	-38.56	-43.19	-28.47	-34.65	-5.99	0.59
Change in Accounts Payable	2.33	4.15	3.84	0.80	1.36	1.90	3.27	-0.02	2.81
Change in Other Working Capital	-2.48	-3.82	6.29	6.40	5.49	2.56	-0.05	-0.17	-0.82
Other Operating Activities	14.94	-82.12	6.29	12.35	1.75	1.64	-0.32	0.96	0.64
Net Cash from Operating Activities	50.40	118.67	8.80	-59.51	-112.37	-102.00	-76.19	-62.68	-37.27
Investing Activities
Capital Expenditures	-22.58	-8.23	-4.98	-13.91	-13.51	-12.73	-3.81	-2.10	-2.68
Acquisitions	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.50
Purchases of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-12.50
Sales/Maturities of Investments	0.00	-0.35	-0.21	0.00	0.00	0.00	0.00	0.00	5.39
Other Investing Activities	-0.32	-0.35	-0.21	0.00	0.00	0.00	0.00	0.00	12.50
Net Cash from Investing Activities	-21.89	-8.58	-4.98	-13.91	-13.51	-12.72	-3.81	-2.10	15.21
Financing Activities
Debt Repayment	-33.44	-60.00	-158.60	51.71	-0.03	13.52	42.47	-0.04	24.98
Common Stock Issued	2.98	7.49	1.10	64.65	121.14	131.20	48.40	42.94	39.20
Common Stock Repurchased	-41.49	-4.97	-1.42	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	-4.58	-0.83	-16.49	-7.51	-0.06	-0.82	-10.86	0.01	-3.43
Net Cash from Financing Activities	-44.02	-58.30	-38.99	108.85	121.05	143.90	80.00	42.92	60.75
Summary
Net Change in Cash	-15.52	51.80	-35.17	35.43	-4.83	29.17	0.00	-21.85	38.69
Cash at Beginning of Period	103.15	51.35	86.52	51.09	55.92	26.75	26.75	48.61	9.91
Cash at End of Period	87.63	103.15	51.35	86.52	51.09	55.92	26.75	26.75	48.61
Free Cash Flow	27.82	110.45	3.82	-73.42	-125.88	-114.73	-80.01	-64.77	-39.95
Supplemental Disclosures
Interest Paid	-	10.67	18.05	13.88	11.16	10.27	-	-	-
Income Taxes Paid	-	9.39	-	-	-	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ADMA Biologics Cash Flow

What is ADMA Biologics's free cash flow?

ADMA Biologics generated free cash flow of $27.82M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $50.40M minus $22.57M of capital expenditures. That was down 74.8% from $110.45M a year earlier. Free cash flow equaled 5.5% of revenue.

How much does ADMA Biologics spend on capital expenditures?

ADMA Biologics spent $22.57M on capital expenditures in fiscal 2025, compared with $8.23M a year earlier. That equals 44.8% of operating cash flow.

Does ADMA Biologics pay dividends or buy back shares?

Yes. In fiscal 2025 ADMA Biologics returned $41.49M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition